These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10712817)

  • 21. Cytochalasin B potentiates epinephrine's outflow facility-increasing effect.
    Robinson JC; Kaufman PL
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1614-8. PubMed ID: 2016142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys.
    Tian B; Gabelt BT; Peterson JA; Kiland JA; Kaufman PL
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):239-42. PubMed ID: 9888449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of latrunculin reveal requirements for the actin cytoskeleton during secretion from mast cells.
    Pendleton A; Koffer A
    Cell Motil Cytoskeleton; 2001 Jan; 48(1):37-51. PubMed ID: 11124709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of Latrunculin-A on myofibrils in cultures of skeletal muscle cells: insights into mechanisms of myofibrillogenesis.
    Wang J; Sanger JM; Sanger JW
    Cell Motil Cytoskeleton; 2005 Sep; 62(1):35-47. PubMed ID: 16080205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anterior segment physiology after bumetanide inhibition of Na-K-Cl cotransport.
    Gabelt BT; Wiederholt M; Clark AF; Kaufman PL
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1700-7. PubMed ID: 9286258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells.
    Thomasy SM; Wood JA; Kass PH; Murphy CJ; Russell P
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):952-8. PubMed ID: 22247475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of latrunculin-A, an actin monomer-binding drug.
    Ayscough K
    Methods Enzymol; 1998; 298():18-25. PubMed ID: 9751867
    [No Abstract]   [Full Text] [Related]  

  • 28. Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D.
    Spector I; Shochet NR; Blasberger D; Kashman Y
    Cell Motil Cytoskeleton; 1989; 13(3):127-44. PubMed ID: 2776221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoregulation of actin synthesis responds to monomeric actin levels.
    Lyubimova A; Bershadsky AD; Ben-Ze'ev A
    J Cell Biochem; 1997 Jun; 65(4):469-78. PubMed ID: 9178097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latrunculin A is a potent inducer of aggregation of polymorphonuclear leukocytes.
    Oliveira CA; Chedraoui S; Mantovani B
    Life Sci; 1997; 61(6):603-9. PubMed ID: 9250716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H-7 effect on outflow facility after trabecular obstruction following long-term echothiophate treatment in monkeys.
    Gabelt BT; Hennes EA; Seeman JL; Tian B; Kaufman PL
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2732-6. PubMed ID: 15277498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ouabain-induced changes in aqueous humour outflow facility and trabecular meshwork cytoskeleton.
    Dismuke WM; Mbadugha CC; Faison D; Ellis DZ
    Br J Ophthalmol; 2009 Jan; 93(1):104-9. PubMed ID: 18971239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfilament-disrupting agent latrunculin A induces and increased number of fenestrae in rat liver sinusoidal endothelial cells: comparison with cytochalasin B.
    Braet F; De Zanger R; Jans D; Spector I; Wisse E
    Hepatology; 1996 Sep; 24(3):627-35. PubMed ID: 8781335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells.
    Spector I; Shochet NR; Kashman Y; Groweiss A
    Science; 1983 Feb; 219(4584):493-5. PubMed ID: 6681676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ML-7, chelerythrine and phorbol ester increase outflow facility in the monkey Eye.
    Tian B; Brumback LC; Kaufman PL
    Exp Eye Res; 2000 Dec; 71(6):551-66. PubMed ID: 11095907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica.
    Vilozny B; Amagata T; Mooberry SL; Crews P
    J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental obstruction to aqueous outflow by pigment particles in living monkeys.
    Epstein DL; Freddo TF; Anderson PJ; Patterson MM; Bassett-Chu S
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):387-95. PubMed ID: 3949467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of actin microfilaments in the down-regulation of the degranulation response in RBL-2H3 mast cells.
    Frigeri L; Apgar JR
    J Immunol; 1999 Feb; 162(4):2243-50. PubMed ID: 9973500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
    Zhong L; Geng L; Njie Y; Feng W; Song ZH
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1988-92. PubMed ID: 15914613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phalloidin inhibits epinephrine's and cytochalasin B's facilitation of aqueous outflow.
    Robinson JC; Kaufman PL
    Arch Ophthalmol; 1994 Dec; 112(12):1610-3. PubMed ID: 7993218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.